Chugai Pharmaceutical Co., Ltd. CHGCY
22.26 USD -0.05 (-0.22%)
Regular-session close
22.19 Day range 22.55
18.33 52-week range 34.84
- YTD
- -15.26%
- 1 year
- -13.79%
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
28.02 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
A-4 / 5 overall
- DCF 3
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 4
- P/E 2
- P/B 2
Valuation
P/E 29.8×
P/S 10.3×
P/B 6.7×
P/FCF 41.3×
EV/EBITDA 19.9×
EV/Sales 10.0×
FCF Yield 2.4%
Profitability
Gross Margin 71.1%
Operating Margin 46.9%
Net Margin 34.5%
ROE 22.4%
ROIC 21.7%
ROA 18.4%
Growth (YoY)
Revenue 12.7%
Operating Income 14.2%
EPS (diluted) 17.5%
Free Cash Flow -16.4%
Financial Health
Current Ratio 4.2×
Quick Ratio 3.6×
Debt / Equity 0.0×
Net Debt / EBITDA -0.6×
Interest Coverage 575×
Dividends
Dividend Yield 2.3%
Payout Ratio 69.0%
Annual · latest fiscal year ends 2025-12-31
